Cargando…
miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732157/ https://www.ncbi.nlm.nih.gov/pubmed/33324102 http://dx.doi.org/10.2147/CMAR.S295016 |
Ejemplares similares
-
miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1
por: Bai, Peide, et al.
Publicado: (2020) -
[Retracted] miR‑489 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways
por: Wang, Wei, et al.
Publicado: (2023) -
Retracted: miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction]
Publicado: (2023) -
Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression
por: Hu, Yue-Mei, et al.
Publicado: (2022)